We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,160

Network interference - a legal guide to the commercial risks and rewards of the social media phenomenon
  • Reed Smith LLP
  • European Union, Global, United Kingdom, USA
  • April 22 2014

Social media is a revolution in the way in which corporations communicate with consumers. This White Paper will help you to maximise the huge


How to handle homeopathy?
  • Reed Smith LLP
  • USA
  • August 12 2015

Search for "homeopathy" on the Internet, and one quickly discovers that this particular form of "alternative medicine," does not have the greatest


PMA medical device preemption decision better late than never
  • Reed Smith LLP
  • USA
  • August 20 2015

We recently learned of Thomas v. Alcon Laboratories, ___ F. Supp.3d ___, 2013 WL 10888983 (N.D. Ga. Jan. 29, 2013), dismissing a contact lens product


Central District of California discontinues much of Plaintiffs' experts' testimony in Cymbalta discontinuation symptoms case
  • Reed Smith LLP
  • USA
  • August 22 2015

"I'm not a doctor, but I play one on TV" - shorthand for "I am pretending to know what I'm talking about, but I really don't." We have blogged


HHS invites comments on advancing interoperability and health information exchange
  • Reed Smith LLP
  • USA
  • March 13 2013

CMS and the Office of the National Coordinator for Health Information Technology (ONC) are seeking comments on a series of potential policies


Preemption (and other things) defanging Depakote claims
  • Reed Smith LLP
  • USA
  • August 24 2015

It wasn't a complete win, but the summary judgment outcome in Rheinfrank v. Abbott Laboratories, Inc., ___ F. Supp.3d ___, 2015 WL 4743056 (S.D. Ohio


SDNY dismisses manufacturing and fraud claims in fertility drug case, but conflates and confuses the rest
  • Reed Smith LLP
  • USA
  • August 26 2015

By all rights, it should be Sullivan writing about the Sullivan case. But John is taking a well-deserved vacation. We do not know if Sullivan's


OIG will not impose sanctions on entities for program that provides free drugs to patients experiencing delayed insurance approvals
  • Reed Smith LLP
  • USA
  • August 19 2015

On August 5, 2015, the Department of Health and Human Services ("HHS") Office of Inspector General ("OIG) issued Advisory Opinion No. 15-11 (the


OIG reviews overlap between physician-owned hospitals and physician-owned distributors (PODs) of spinal devices
  • Reed Smith LLP
  • USA
  • August 26 2015

The Office of Inspector General (OIG) of the Department of Health and Human Services has issued a report on “Overlap Between Physician-Owned


CMS seeks feedback on home health face-to-face encounter clinical templates
  • Reed Smith LLP
  • USA
  • August 26 2015

CMS is inviting comments on voluntary home health electronic and paper “progress note” templates intended to assist physicians with documenting a